Spots Global Cancer Trial Database for soft tissue sarcoma adult
Every month we try and update this database with for soft tissue sarcoma adult cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Prospective Identification of Predictive Biomarkers of Trabectedin Efficacy in Non-L Soft-tissue Sarcoma Patients | NCT04008238 | Soft Tissue Sar... Undifferentiate... Epithelioid Sar... Solitary Fibrou... Hemangioendothe... Desmoplastic Ro... Synovial Sarcom... | Trabectedin | 18 Years - | Institut Bergonié | |
Radiation Effects on Bone | NCT03134742 | Soft Tissue Sar... | Control Group CT Scan DEXA Scans CT and DEXA Sca... | 18 Years - 89 Years | State University of New York - Upstate Medical University | |
Quality of Life in Patients With Non-adipocyte Soft Tissue Sarcoma Under Palliative Chemotherapy or Pazopanib | NCT03735758 | Soft Tissue Sar... | pazopanib or gu... | 18 Years - | GWT-TUD GmbH | |
Propranolol and Pembrolizumab in Advanced Soft Tissue Sarcoma Patients | NCT05961761 | Soft Tissue Sar... Angiosarcoma Undifferentiate... | Propranolol Pembrolizumab | 18 Years - | Herlev and Gentofte Hospital | |
Sarcomas and DDR-Inhibition; a Combined Modality Study | NCT05116254 | Soft Tissue Sar... | AZD1390 + radio... AZD1390 + durvl... | 18 Years - | The Netherlands Cancer Institute | |
Apatinib for Advanced Soft Tissue Sarcoma Patients: a Phase 2, Multicenter Trial | NCT03104335 | Soft Tissue Sar... Advanced Cancer | Apatinib | 16 Years - | Peking University People's Hospital | |
Combined Treatment of Patients With Soft Tissue Sarcoma Including Preoperative Stereotactic Radiation Therapy and Postoperative Conformal Radiation Therapy | NCT04330456 | Soft Tissue Sar... | Preoperative st... Surgery Postoperative c... | 18 Years - 75 Years | N.N. Petrov National Medical Research Center of Oncology | |
Apatinib for Advanced Soft Tissue Sarcoma Patients: a Phase 2, Multicenter Trial | NCT03104335 | Soft Tissue Sar... Advanced Cancer | Apatinib | 16 Years - | Peking University People's Hospital | |
Quality of Life in Patients With Non-adipocyte Soft Tissue Sarcoma Under Palliative Chemotherapy or Pazopanib | NCT03735758 | Soft Tissue Sar... | pazopanib or gu... | 18 Years - | GWT-TUD GmbH | |
Low Dose Continuous Cyclophosphamide vs Standard Doxorubicin in Advanced Sarcoma Elderly Patients | NCT04656262 | Soft Tissue Sar... | Cyclophosphamid... Doxorubicin | 70 Years - | Istituto Oncologico Veneto IRCCS | |
A Study of Surufatinib in the Treatment of Advanced Soft Tissue Sarcoma | NCT06110650 | Soft Tissue Sar... | Surufatinib | 18 Years - | Fudan University | |
Study of a Cohort of Cases of Synovial Sarcoma Treated in the Orthopedic Surgery and Traumatology Department of the Hospital de Sant Pau Between 1983 and 2016 | NCT03833037 | Soft Tissue Sar... | Soft tissue sar... | 10 Years - 100 Years | Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau | |
Fluorescent Aided Resection and Evaluation of Soft Tissue Sarcomas (FLARES) | NCT06252727 | Soft Tissue Sar... Soft Tissue Sar... | Aminolevulinic ... | 18 Years - | University of California, Davis | |
Blood and Tissue Extraction for Immunological Examinations During Neoadjuvant Therapy of Soft Tissue Sarcomas | NCT06385288 | Soft Tissue Sar... | Blood and tissu... neoadjuvant The... | 18 Years - | University Hospital Tuebingen | |
Efficacy and Safety of Anlotinib in Adjuvant Therapy for High-grade Soft Tissue Sarcoma | NCT03951571 | Soft Tissue Sar... High Grade Sarc... | Anlotinib Hydro... Placebo Oral Ta... | 18 Years - | Fudan University | |
Sarcomas and DDR-Inhibition; a Combined Modality Study | NCT05116254 | Soft Tissue Sar... | AZD1390 + radio... AZD1390 + durvl... | 18 Years - | The Netherlands Cancer Institute | |
Pre-operative RadiothErapy for Soft Tissue SarcOmas | NCT04617327 | Soft Tissue Sar... | Hypofractionati... | 18 Years - | McGill University Health Centre/Research Institute of the McGill University Health Centre | |
Combination of Nivolumab Plus Relatlimab in Patients With Advanced or Metastatic Soft-tissue Sarcoma: a Proof-of-concept Randomized Phase II Study | NCT04095208 | Soft Tissue Sar... Advanced Cancer | Association of ... Nivolumab | 18 Years - | Institut Bergonié | |
Impact of Locoregional Treatment of Soft Tissue Sarcoma on Status of Patients Aged 70 Years and Over | NCT03077178 | Soft Tissue Sar... | Geriatric asses... | 70 Years - | Institut Bergonié | |
Combination of Nivolumab Plus Relatlimab in Patients With Advanced or Metastatic Soft-tissue Sarcoma: a Proof-of-concept Randomized Phase II Study | NCT04095208 | Soft Tissue Sar... Advanced Cancer | Association of ... Nivolumab | 18 Years - | Institut Bergonié | |
Precise Local Injection of Anti-cancer Drugs Using Presage's CIVO Device in Soft Tissue Sarcoma | NCT03056599 | Soft Tissue Sar... | Multiple drug m... CIVO device | 18 Years - | Presage Biosciences | |
Low Dose Continuous Cyclophosphamide vs Standard Doxorubicin in Advanced Sarcoma Elderly Patients | NCT04656262 | Soft Tissue Sar... | Cyclophosphamid... Doxorubicin | 70 Years - | Istituto Oncologico Veneto IRCCS |